Recap: Marinus Pharmaceuticals Q3 Earnings

  Marinus Pharmaceuticals (NASDAQ:MRNS) reported its Q3 earnings results on Tuesday, November 9, 2021 at 08:00 AM. Here's what investors need to know about the announcement.

 

Marinus Pharmaceuticals (NASDAQ:MRNS) reported its Q3 earnings results on Tuesday, November 9, 2021 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Marinus Pharmaceuticals their estimated earnings by 27.4%, reporting an EPS of $-0.53 versus an estimate of $-0.73, which surprised analysts.

Revenue was up $9,943,000 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04, which was followed by a 3.96% drop in the share price the next day.

Here’s a look at Marinus Pharmaceuticals’s past performance:

 

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020
EPS Estimate -0.69 -0.45 -0.51 -0.60
EPS Actual -0.65 -0.74 -0.55 -0.51
Revenue Estimate 2.70M 2.57M 1.04M 420.00K
Revenue Actual 1.91M 1.81M 1.55M 171.00K

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

Total
0
Shares
Related Posts
Read More

On December 5, In Light Of The Departure Of Christina Spade, The Company’s Former CEO, The Board Of Directors Of AMC Networks Appointed James L. Dolan, The Company’s Current Chairman Of The Board Of Directors, As Interim Executive Chairman Of The Compa…

Appointment of James L. Dolan as Interim Executive Chairman On December 5, 2022, in light of the departure of Christina Spade, the Company’s former Chief Executive Officer, the Board of Directors of AMC Networks

AMCX